Fundamental Research Division
The DRF at the CEA assemble approximately 6,000 scientists since January 2016.
You are in industry: five reasons to collaborate with the DSV on your innovative projects
The CEA’s Life Sciences
Division (Direction des sciences
du vivant - DSV) supports and contributes to
the innovation of businesses by providing them with its scientific expertise
and technologies. It offers a wide variety of services to respond to the needs
of the pharmaceutical, diagnostic, biotech, medtech and greentech industries.
The coexistence of basic and applied research within the DSV, as well as transfers between the two, guarantees the technological maturity needed to create industrial value.
In the field of health, the DSV masters all stages of drug development, from identification of therapeutic or diagnostic approaches to clinical research, while proposing tools to monitor clinical trials.
In the field of bioenergy, the DSV is capable of conducting R&D projects extending up to an industrial scale.
accompanies this technological maturation by directly acting on its financing.
For example, it coordinates the “Technologies for Health” program, which
involves all CEA operational sectors. The program singles out ideas that have a
strong potential for industrial transfer, in order to facilitate their
development and accelerate their arrival on the market. It also accompanies the
proof of concept and prototype realization stages, two key steps in the
processes of value-creation and transfer to companies.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.